Survival with kidney failure ranges from days to decades, depending on the type of failure, the treatment chosen, and the person’s age and overall health. Someone who receives a kidney transplant in their twenties can live for many more decades, while an older adult with multiple chronic conditions who forgoes dialysis may survive only a few months. The question “how long” never has a single answer because kidney failure is not one situation; it is a spectrum of severity, and the person attached to those kidneys matters as much as the kidneys themselves.
How Kidney Function Loss Shortens Life Expectancy
The reduction in life expectancy from kidney disease is not something that begins only when the kidneys stop working entirely. Research from a large Canadian registry showed that the loss begins at a kidney filtration rate below about 60 mL/min, which is considered moderate kidney disease, well before anyone would need dialysis.1PubMed Central. Life expectancy with chronic kidney disease: an educational review In practical terms, a 40-year-old man with normal kidney function could expect to live roughly 30 more years. At moderately reduced function, that dropped to about 24 years. At more severely reduced function, it fell to around 14 years. For a 40-year-old woman, the pattern was similar, starting at about 35 years of remaining life with healthy kidneys and declining with each drop in function.2Nephrology Dialysis Transplantation. Chronic kidney disease and life expectancy
This matters because it reframes the question. Many people imagine kidney failure as a sudden event followed by a stark choice between dialysis and death. In reality, most people with kidney failure have experienced years of gradual decline, and the accumulated damage to the heart and blood vessels during those years is what drives much of the mortality risk once they reach the final stage.
Survival on Dialysis
Dialysis is the treatment most people associate with kidney failure, and the survival statistics are sobering. One widely cited figure puts average life expectancy on hemodialysis at less than three years, a number that had not meaningfully improved over two decades when it was reported.3PubMed Central. Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation That average, though, conceals enormous variation. An Iranian study that followed hemodialysis patients found a median survival of six years and a five-year survival rate of about 54%.4PubMed Central. Estimating the Loss in Expectation of Life and Relative Survival Rate among Hemodialysis Patients in Iran A U.S. study of older adults with kidney failure found that five-year relative survival, after adjusting for age and other conditions, was roughly 31 to 36%.5American Journal of Kidney Diseases. Using Relative Survival to Estimate the Burden of Kidney Failure
Age at the start of dialysis is the single biggest determinant. Survival rates drop steeply with each additional decade of life. Among older patients with diabetic kidney disease, outcomes are particularly poor: one study found that no patient aged 85 or older with diabetic nephropathy survived five years on dialysis.6JAMA. Effect of Age and Diagnosis on Survival of Older Patients Beginning Chronic Dialysis Meanwhile, a younger person starting dialysis in their thirties or forties without diabetes can realistically expect many more years, especially if they are on a transplant waiting list.
Hemodialysis Versus Peritoneal Dialysis
The two main forms of dialysis are hemodialysis, typically done at a clinic three times a week, and peritoneal dialysis, which patients perform at home using the lining of their abdomen as a filter. Patients and families often want to know which one offers better survival, and the honest answer is that the evidence has gone back and forth for years.
In the short term, peritoneal dialysis appears to perform at least as well. One study found that peritoneal dialysis was associated with roughly 48% lower mortality than hemodialysis over the first two years, even after accounting for patients who switched modalities or received transplants.7PubMed Central. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis But in the long run, the picture reverses. A large retrospective study found no significant difference in mortality between the two groups for the first four years, but at five and ten years, the hemodialysis group had lower mortality rates.8PubMed Central. Long-term mortality in patients with end-stage renal disease undergoing hemodialysis and peritoneal dialysis: a propensity score matching retrospective study A meta-analysis focusing on older adults similarly found that peritoneal dialysis carried a higher overall mortality rate, particularly in people with diabetes or significant other illnesses.9PubMed Central. Mortality of Peritoneal Dialysis versus Hemodialysis in Older Adults: An Updated Systematic Review and Meta-Analysis
The practical takeaway is that peritoneal dialysis can be a reasonable or even preferable choice for many patients in the first few years, especially for quality-of-life reasons like independence and flexibility. Over longer periods, hemodialysis may have a survival edge, though the difference is influenced heavily by a patient’s age, diabetes status, and other illnesses.
Kidney Transplantation Changes the Math
A successful kidney transplant offers the best survival of any treatment for kidney failure. Compared with staying on dialysis, transplant recipients consistently live longer. A living-donor kidney tends to outperform a deceased-donor kidney: a large UK cohort study found that living-donor recipients had about a 6% lower five-year risk of graft failure and gained about four additional months of graft survival over seven years compared with deceased-donor recipients.10PubMed Central. Comparison of outcomes after living and deceased donor kidney transplantation: UK national cohort study Receiving a kidney from a living donor was also an independent predictor of long-term survival in a separate population-based analysis.11Scientific Reports. Life expectancy after kidney transplantation in a population-based retrospective cohort The survival benefit of a living-donor kidney held across all age groups, although the advantage over deceased-donor kidneys narrowed somewhat for recipients older than 70.12PubMed Central. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes
Not everyone is eligible for a transplant, however. The evaluation process considers heart health, cancer history, infection risk, and whether the person can reliably take immunosuppressive medications for life. Frailty alone can reduce access to transplantation, as one study found that frail patients were significantly less likely to be placed on a transplant list.13BMJ Open. Longitudinal frailty assessment in the prediction of survival among patients with advanced chronic kidney disease: a prospective observational single-centre cohort study The organ shortage also means many patients wait years on dialysis before a deceased-donor kidney becomes available, and some never receive one.
Choosing Not to Dialyze
A growing number of older patients with kidney failure, especially those with serious additional health problems, choose conservative kidney management instead of starting dialysis. This means focusing on symptom control, quality of life, and sometimes hospice care rather than the demanding schedule of dialysis treatments.
A systematic review of studies on conservative management found that median survival ranged widely, from about 6 months to nearly 2 years, depending on the population studied and how much kidney function remained at the time of the decision.14PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review A larger systematic review published in JAMA Network Open reported an even broader range, with median survival spanning 1 to 41 months. Physical well-being and overall quality of life tended to remain stable until late in the illness.15JAMA Network Open. Long-term Outcomes Among Patients With Advanced Kidney Disease Who Forgo Maintenance Dialysis: A Systematic Review
Does dialysis always extend life compared with conservative care? Not necessarily, especially for the very old. In patients over 75, after adjusting for age, diabetes, and other conditions, dialysis conferred only about four extra months of survival compared with conservative management, and that difference was not statistically significant.16PubMed Central. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy A more recent systematic review confirmed the pattern: while dialysis was associated with lower mortality overall, for patients aged 80 and older and those with significant comorbidities, the results were ambiguous, and conservative management appeared to offer advantages in quality of life.17PubMed Central. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review These findings have shifted the conversation in nephrology. For an 82-year-old with heart failure and limited mobility, the time spent traveling to and recovering from dialysis sessions may not produce a meaningful survival gain, and it may reduce the quality of the time that remains.
When Kidneys Fail Suddenly
Everything discussed so far deals with chronic kidney failure, the gradual kind. Acute kidney injury is a different situation, where the kidneys shut down rapidly, often during a severe illness, a major surgery, or a toxic exposure. Many people with acute kidney injury recover enough function to come off dialysis entirely, but the episode leaves a mark. A study that followed patients after acute kidney injury requiring dialysis in intensive care found that about 5% remained on dialysis long-term.18PLoS Medicine. Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial
Even among those who do recover kidney function, the long-term outlook is worse than for people who never had the injury. A study of patients who survived acute kidney injury found three-year survival of 67% overall, but that number dropped to 50% for those who had pre-existing kidney disease before the acute episode.19PubMed. Long-term prognosis after acute kidney injury requiring renal replacement therapy Patients who began outpatient dialysis after an acute kidney injury episode had about 22% higher adjusted mortality than those who started dialysis for chronic reasons.20PubMed Central. Acute Kidney Injury Requiring Dialysis and Incident Dialysis Patient Outcomes in US Outpatient Dialysis Facilities That gap narrowed after about four months, but it underlines how a sudden kidney crisis can be more dangerous than a slow decline, at least initially.
Children and Young Adults With Kidney Failure
Kidney failure in children is rare, but when it occurs, the life-years lost are devastating. A binational cohort study found that children with kidney failure lost between 16 and 32 years of life expectancy compared with healthy peers, with the greatest loss among girls and those who developed kidney failure at the youngest ages.21PubMed Central. Life Years Lost in Children with Kidney Failure: A Binational Cohort Study with Multistate Probabilities of Death and Life Expectancy A large registry study following over 1,600 children found that 79% survived to 10 years and 66% to 20 years after starting treatment, but their death rate was still about 30 times higher than for children without kidney failure.22PubMed. Long-term survival of children with end-stage renal disease The youngest children, especially those under one year old, faced the highest risk, and children on dialysis had more than four times the death risk of those with a functioning transplant.
As with adults, transplantation dramatically improves the picture for children. But even with a transplant, children with kidney failure spend a large portion of their remaining years on dialysis before and between transplants, and their cardiovascular risk stays elevated for life.23PubMed Central. Epidemiology of chronic kidney disease in children
What People With Kidney Failure Actually Die From
You might assume that people with kidney failure die from the kidney failure itself, from the buildup of toxins the kidneys can no longer clear. In reality, the leading causes of death on dialysis are infections and cardiovascular events. One analysis found that infections accounted for more than 36% of all deaths among dialysis patients, while cardiac causes accounted for about 14%. Withdrawal from dialysis, an intentional decision to stop treatment, was the cause in about 21% of deaths and was most common in patients over 61.24PubMed. Mortality in dialysis patients: analysis of the causes of death
The high rate of death from infection reflects the fact that dialysis patients have weakened immune systems and are exposed to infection risks through their dialysis access (the catheter or fistula connecting them to the machine). Cardiovascular disease is driven by years of high blood pressure, fluid overload, and metabolic disturbances that accumulate over the course of kidney disease. Having both diabetes and kidney disease is especially lethal: a study found that the standardized mortality rate among people with both conditions was about 31%, and kidney disease was the primary driver of that excess mortality, not the diabetes alone.25PubMed Central. Kidney disease and increased mortality risk in type 2 diabetes
Factors That Predict Who Lives Longer
Beyond age and diabetes, several less obvious factors influence survival with kidney failure. Frailty, a clinical measure of overall weakness and vulnerability, outperformed age, comorbidity counts, and lab values in predicting death risk in one prospective study, roughly tripling the mortality risk.13BMJ Open. Longitudinal frailty assessment in the prediction of survival among patients with advanced chronic kidney disease: a prospective observational single-centre cohort study Malnutrition matters too: among patients managed conservatively without dialysis, being malnourished roughly doubled the risk of death over two years.26PubMed Central. The impact of frailty and malnutrition on hospitalisation and survival in people with kidney failure The muscle wasting and weight loss known as protein-energy wasting is common in advanced kidney disease and strongly linked to cardiovascular death.27PubMed Central. Protein-energy wasting and mortality in chronic kidney disease
Mental health plays a role that is often underappreciated. Depression is common among dialysis patients and carries a real survival cost. A meta-analysis found that dialysis patients with depression had about 15% higher mortality, and those with severe depression had roughly 42% higher death rates compared with non-depressed peers.28PubMed Central. Outcomes in end-stage renal disease dialysis patients with depression Another study found that poor self-reported mental health independently predicted higher one-year mortality, even after adjusting for physical health scores.29Kidney International. The association between mental health, physical function, and hemodialysis mortality This does not mean depression “causes” death directly, but it likely contributes through poorer self-care, skipped treatments, and biological pathways like chronic inflammation.
Racial and Socioeconomic Disparities
Survival with kidney failure is shaped by factors beyond biology. Black hemodialysis patients in the United States live in areas with lower household incomes on average, and residence in highly segregated areas was independently associated with higher mortality among Black patients.30PubMed Central. Segregation, income disparities, and survival in hemodialysis patients At the same time, the relationship between race and dialysis survival is not straightforward. After adjusting for other factors, African American hemodialysis patients actually had lower adjusted mortality than non-African American patients across all income levels, a finding sometimes called the “dialysis survival paradox.”31PubMed. Do income level and race influence survival in patients receiving hemodialysis? However, this paradox does not hold universally. Young African American patients with kidney failure caused by lupus nephritis had a significantly higher death risk than their non-African American counterparts.32PubMed. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE
Global disparities are even starker. Dialysis outcomes vary dramatically across countries and income levels, with infections and social factors contributing disproportionately to death and hospitalization in lower-income countries where dialysis infrastructure and supportive care are more limited.33PubMed Central. Dialysis Outcomes Across Countries and Regions: A Global Perspective From the International Society of Nephrology Global Kidney Health Atlas Study
What Happens When Dialysis Stops
For patients who choose to withdraw from dialysis, either because they are too ill to continue or because they decide the treatment burden is no longer worth it, death typically comes quickly. A study of nearly 2,000 patients who discontinued dialysis and enrolled in hospice found that average survival after stopping was about 7 days, with a range from the same day up to 40 days.34PubMed Central. Survival after dialysis discontinuation and hospice enrollment for ESRD Another study found a similar average of about 8 days, with half of patients dying within 6 days of their last dialysis session.35JAMA Internal Medicine. Dying Well After Discontinuing the Life-Support Treatment of Dialysis A handful of patients in that study survived 30 to 46 days, likely because they had some residual kidney function.
Withdrawal from dialysis is far from rare. As noted earlier, it accounts for roughly one in five deaths among dialysis patients, and it is especially common among older patients. The short survival window after stopping underscores how completely these patients depend on the machine and how important advance planning is for anyone on dialysis.
Treatments That Are Shifting the Timeline
Two areas of recent progress are worth noting for their potential to change survival numbers in the coming years. The first is a class of drugs called SGLT2 inhibitors, originally developed for diabetes but now recognized as important kidney-protective medications. These drugs slow the decline of kidney function through mechanisms that are independent of blood sugar control.36PubMed Central. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations In patients with advanced kidney disease and type 2 diabetes, SGLT2 inhibitors were associated with a significantly lower risk of progressing to complete kidney failure.37Scientific Reports. SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM A modeling study estimated that combining SGLT2 inhibitors with other newer therapies could add roughly 2.4 years of life free from death and over 5 additional years free from kidney disease progression in high-risk patients with diabetes.38PubMed. Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
The second development is hemodiafiltration, an advanced form of dialysis that combines traditional hemodialysis with additional fluid filtration. A meta-analysis found that hemodiafiltration reduced all-cause mortality by about 16% and cardiovascular mortality by about 26% compared with standard hemodialysis, though the benefit was strongest when higher volumes of fluid were filtered during each session.39PubMed Central. Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis Hemodiafiltration has been gaining ground as a potential new standard of care for patients who need long-term dialysis, though availability varies by country and dialysis center.40PubMed Central. Latest Trends in Hemodiafiltration